Do multifocal or multicentric pT1a node-negative HER2+ breast cancers get benefit from systemic treatment? Altundag K. Breast Cancer Res Treat 2020;179:763.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Altundag K. Do multifocal or multicentric pT1a node-negative HER2+ breast cancers get benefit from systemic treatment? Breast Cancer Res Treat 2020;179:763.
PMID: 31838730